Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 748

1.

Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis.

Veehof MM, ten Klooster PM, Taal E, van Riel PL, van de Laar MA.

J Rheumatol. 2008 Apr;35(4):610-7. Epub 2008 Mar 1.

PMID:
18322989
2.

Psychometric properties of a Dutch short form of the Arthritis Impact Measurement Scales 2 (Dutch-AIMS2-SF).

Taal E, Rasker JJ, Riemsma RP.

Rheumatology (Oxford). 2003 Mar;42(3):427-34.

PMID:
12626792
3.

Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.

Salaffi F, Stancati A, Carotti M.

Clin Rheumatol. 2002 Nov;21(6):478-87.

PMID:
12447631
4.
5.

A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients.

Haavardsholm EA, Kvien TK, Uhlig T, Smedstad LM, Guillemin F.

J Rheumatol. 2000 Dec;27(12):2810-6.

PMID:
11128668
6.

Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain.

Taal E, Rasker JJ, Riemsma RP.

Ann Rheum Dis. 2004 Dec;63(12):1655-8.

7.
8.

Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome.

Bessette L, Sangha O, Kuntz KM, Keller RB, Lew RA, Fossel AH, Katz JN.

Med Care. 1998 Apr;36(4):491-502.

PMID:
9544589
10.
11.

Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.

Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE Jr, Perfetto EM.

Am J Manag Care. 2002 Mar;8(3):231-40.

12.

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.

Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH.

Soc Sci Med. 2005 Apr;60(7):1571-82.

PMID:
15652688
13.
14.

Evaluation and cultural adaptation of a German version of the AIMS2-SF questionnaire (German AIMS2-SF).

Rosemann T, Körner T, Wensing M, Schneider A, Szecsenyi J.

Rheumatology (Oxford). 2005 Sep;44(9):1190-5. Epub 2005 Jun 21.

PMID:
15972355
15.

Health status and perception of pain: a comparative study between female patients with hand osteoarthritis and rheumatoid arthritis.

Slatkowsky-Christensen B, Mowinckel P, Kvien TK.

Scand J Rheumatol. 2009;38(5):342-8. doi: 10.1080/03009740902913496.

PMID:
19585382
16.

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.

Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr, Seibold JR; Relaxin Study Group; Scleroderma Clinical Trials Consortium.

J Rheumatol. 2005 May;32(5):832-40.

PMID:
15868618
17.

The SF-36 Arthritis-Specific Health Index (ASHI): II. Tests of validity in four clinical trials.

Keller SD, Ware JE Jr, Hatoum HT, Kong SX.

Med Care. 1999 May;37(5 Suppl):MS51-60.

PMID:
10335743
18.

Assessing responsiveness of generic and specific health related quality of life measures in heart failure.

Eurich DT, Johnson JA, Reid KJ, Spertus JA.

Health Qual Life Outcomes. 2006 Nov 24;4:89.

19.

A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.

Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Buckley LM, Alarcón GS, Trentham DE, Neuner R, Clegg DO, Leisen JC, Heyse SP.

J Rheumatol. 1997 Oct;24(10):1910-5.

PMID:
9330931
20.

Supplemental Content

Support Center